Molecular Detection of Panton Valentine Leukocidin Toxin in Clinical Isolates of Staphylococcus aureus from Kiambu County, Kenya

Panton–Valentine leukocidin gene is produced by Staphylococcus aureus, and methicillin-resistant Staphylococcus aureus isolates as a pore-forming toxin is largely responsible for skin and soft tissue illnesses. MRSA produces PVL toxins through lukS and lukF proteins causing tissue necrosis by damagi...

Full description

Bibliographic Details
Main Authors: Sani Iliya, Jonathan Mwangi, Ronald Maathai, Mary Muriuki, Christopher Wainaina
Format: Article
Language:English
Published: Hindawi Limited 2020-01-01
Series:International Journal of Microbiology
Online Access:http://dx.doi.org/10.1155/2020/3106747
id doaj-5025859bcadd4142b0b8a3e8ffb5b9e6
record_format Article
spelling doaj-5025859bcadd4142b0b8a3e8ffb5b9e62021-07-02T12:53:58ZengHindawi LimitedInternational Journal of Microbiology1687-918X1687-91982020-01-01202010.1155/2020/31067473106747Molecular Detection of Panton Valentine Leukocidin Toxin in Clinical Isolates of Staphylococcus aureus from Kiambu County, KenyaSani Iliya0Jonathan Mwangi1Ronald Maathai2Mary Muriuki3Christopher Wainaina4Department of Biological Sciences, School of Pure and Applied Sciences, Mount Kenya University, Thika, KenyaSchool of Pharmacy and Health Sciences, United States International University-Africa, Nairobi, KenyaDepartment of Biochemistry, Mount Kenya University, Thika, KenyaSchool of Pure and Applied Sciences, Mount Kenya University, Thika, KenyaHain Life Science East Africa Ltd., Nairobi, KenyaPanton–Valentine leukocidin gene is produced by Staphylococcus aureus, and methicillin-resistant Staphylococcus aureus isolates as a pore-forming toxin is largely responsible for skin and soft tissue illnesses. MRSA produces PVL toxins through lukS and lukF proteins causing tissue necrosis by damaging membrane of the defense cells. Presence of PVL toxin was tested from the 54 S. aureus clinical isolates obtained from Thika and Kiambu Level 5 Hospitals, in Kiambu County, Kenya, by Geno Type® MRSA assay (Hain Life Science, Nehren, Germany). DNA was isolated from freshly harvested bacterial cultures by spin column using Geno Type DNA isolation kit. The detection of PVL toxins was performed by amplification of genomic DNA and by reverse hybridization that identifies PVL genes using Geno Type MRSA kit. Out of 138 samples that were collected from patients in Kiambu County, 54 S. aureus isolates were obtained, of which 14 (25.9%; 95% CI = 11.9–38.9) samples had PVL toxins. The isolates that were obtained from the female patients had a higher PVL toxin prevalence of 35.7%, while the isolates collected from the male patients had a lower prevalence of 15.4% (P=0.09). The pediatrics department had the highest PVL gene prevalence compared to outpatient department and surgical units (P=0.08). However, the age groups of patients and the hospital attended by patients showed no significant difference in terms of PVL gene prevalence (P=0.26). Therefore, the patients' gender and hospital units were not significantly associated with PVL gene prevalence (P=0.08). This study shows that PVL positive isolates occur in the sampled hospitals in the county and female as well as children must be taken into consideration among patients with wound infections when isolating S. aureus.http://dx.doi.org/10.1155/2020/3106747
collection DOAJ
language English
format Article
sources DOAJ
author Sani Iliya
Jonathan Mwangi
Ronald Maathai
Mary Muriuki
Christopher Wainaina
spellingShingle Sani Iliya
Jonathan Mwangi
Ronald Maathai
Mary Muriuki
Christopher Wainaina
Molecular Detection of Panton Valentine Leukocidin Toxin in Clinical Isolates of Staphylococcus aureus from Kiambu County, Kenya
International Journal of Microbiology
author_facet Sani Iliya
Jonathan Mwangi
Ronald Maathai
Mary Muriuki
Christopher Wainaina
author_sort Sani Iliya
title Molecular Detection of Panton Valentine Leukocidin Toxin in Clinical Isolates of Staphylococcus aureus from Kiambu County, Kenya
title_short Molecular Detection of Panton Valentine Leukocidin Toxin in Clinical Isolates of Staphylococcus aureus from Kiambu County, Kenya
title_full Molecular Detection of Panton Valentine Leukocidin Toxin in Clinical Isolates of Staphylococcus aureus from Kiambu County, Kenya
title_fullStr Molecular Detection of Panton Valentine Leukocidin Toxin in Clinical Isolates of Staphylococcus aureus from Kiambu County, Kenya
title_full_unstemmed Molecular Detection of Panton Valentine Leukocidin Toxin in Clinical Isolates of Staphylococcus aureus from Kiambu County, Kenya
title_sort molecular detection of panton valentine leukocidin toxin in clinical isolates of staphylococcus aureus from kiambu county, kenya
publisher Hindawi Limited
series International Journal of Microbiology
issn 1687-918X
1687-9198
publishDate 2020-01-01
description Panton–Valentine leukocidin gene is produced by Staphylococcus aureus, and methicillin-resistant Staphylococcus aureus isolates as a pore-forming toxin is largely responsible for skin and soft tissue illnesses. MRSA produces PVL toxins through lukS and lukF proteins causing tissue necrosis by damaging membrane of the defense cells. Presence of PVL toxin was tested from the 54 S. aureus clinical isolates obtained from Thika and Kiambu Level 5 Hospitals, in Kiambu County, Kenya, by Geno Type® MRSA assay (Hain Life Science, Nehren, Germany). DNA was isolated from freshly harvested bacterial cultures by spin column using Geno Type DNA isolation kit. The detection of PVL toxins was performed by amplification of genomic DNA and by reverse hybridization that identifies PVL genes using Geno Type MRSA kit. Out of 138 samples that were collected from patients in Kiambu County, 54 S. aureus isolates were obtained, of which 14 (25.9%; 95% CI = 11.9–38.9) samples had PVL toxins. The isolates that were obtained from the female patients had a higher PVL toxin prevalence of 35.7%, while the isolates collected from the male patients had a lower prevalence of 15.4% (P=0.09). The pediatrics department had the highest PVL gene prevalence compared to outpatient department and surgical units (P=0.08). However, the age groups of patients and the hospital attended by patients showed no significant difference in terms of PVL gene prevalence (P=0.26). Therefore, the patients' gender and hospital units were not significantly associated with PVL gene prevalence (P=0.08). This study shows that PVL positive isolates occur in the sampled hospitals in the county and female as well as children must be taken into consideration among patients with wound infections when isolating S. aureus.
url http://dx.doi.org/10.1155/2020/3106747
work_keys_str_mv AT saniiliya moleculardetectionofpantonvalentineleukocidintoxininclinicalisolatesofstaphylococcusaureusfromkiambucountykenya
AT jonathanmwangi moleculardetectionofpantonvalentineleukocidintoxininclinicalisolatesofstaphylococcusaureusfromkiambucountykenya
AT ronaldmaathai moleculardetectionofpantonvalentineleukocidintoxininclinicalisolatesofstaphylococcusaureusfromkiambucountykenya
AT marymuriuki moleculardetectionofpantonvalentineleukocidintoxininclinicalisolatesofstaphylococcusaureusfromkiambucountykenya
AT christopherwainaina moleculardetectionofpantonvalentineleukocidintoxininclinicalisolatesofstaphylococcusaureusfromkiambucountykenya
_version_ 1721329651474759680